このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

The Effect of Virtual Reality Glasses Applied to Hemodialysis Patients on Vital Signs and Anxiety Level

2026年7月9日 更新者:Ankara Yildirim Beyazıt University
This randomized controlled experimental study was conducted to evaluate the effects of virtual reality glasses used during hemodialysis on patients' vital signs and anxiety levels. A total of 56 adult patients receiving hemodialysis at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital were randomly assigned to either an experimental group or a control group. Patients in the experimental group watched a 4K virtual reality nature video with relaxing background music during hemodialysis, while the control group received standard hemodialysis care. Vital signs, pain, anxiety, and satisfaction were assessed to evaluate the effectiveness of the virtual reality intervention.

調査の概要

詳細な説明

The research was designed and conducted as a randomized controlled experimental study to determine the effects of virtual reality glasses on the vital signs and anxiety levels of hemodialysis patients.

The study population consisted of patients diagnosed with kidney failure who received hemodialysis at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between May 2023 and May 2024. A total of 56 patients who volunteered to participate and met the inclusion criteria were included in the study. These patients were randomly assigned to two homogeneous groups according to gender and type of renal failure (acute/chronic): an experimental group (n=28) and a control group (n=28).

Patients in the experimental group watched a 4K virtual reality video featuring natural scenery accompanied by relaxing background music through virtual reality glasses during hemodialysis, whereas patients in the control group received standard hemodialysis care without any additional intervention.

Data were collected using the Patient Information Form, Vital Signs Follow-up Form, Visual Analog Scale for Pain (VAS), State Anxiety Scale, and Visual Analog Scale for Satisfaction (VAS-Satisfaction). Ethics committee approval, institutional permission, and written informed consent were obtained before the study was conducted.

研究の種類

介入

入学 (実際)

56

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Ankara、トルコ(Türkiye)、06200
        • Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Receiving hemodialysis treatment for the first time.
  • Age ≥18 years.
  • No visual, hearing, or cognitive impairment.
  • Able to communicate effectively.
  • Clinically stable.
  • No diagnosed psychiatric disorder or use of psychiatric medication.
  • No history of seizures.
  • Willing and able to provide informed consent.

Exclusion Criteria:

  • Previous hemodialysis treatment.
  • Age <18 years.
  • Visual, hearing, or cognitive impairment.
  • History of kidney transplantation.
  • Communication difficulties.
  • Diagnosed psychiatric disorder or use of psychiatric medication.
  • History of seizures.
  • Declined to participate in the study.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:支持療法
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Experimental Group
Participants received a virtual reality intervention during hemodialysis in addition to standard care.
Participants wore virtual reality glasses at the start of the hemodialysis session and viewed a 4K nature video with calming background music for 15 minutes. The intervention was administered once during the hemodialysis session in addition to standard hemodialysis care.
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.
アクティブコンパレータ:Control Group
Participants received standard hemodialysis care without any additional intervention.
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change in Systolic Blood Pressure
時間枠:Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in systolic blood pressure measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Diastolic Blood Pressure
時間枠:Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in diastolic blood pressure measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Heart Rate
時間枠:Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in heart rate measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Respiratory Rate
時間枠:Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in respiratory rate measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Peripheral Oxygen Saturation (SpO₂)
時間枠:Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in peripheral oxygen saturation (SpO₂) measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Body Temperature
時間枠:Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in body temperature measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
State Anxiety Level After Hemodialysis
時間枠:Immediately after completion of the hemodialysis session.
State anxiety measured using the State Anxiety Inventory (STAI-State), a 20-item questionnaire with total scores ranging from 20 to 80. Higher scores indicate greater levels of state anxiety. Assessment was performed immediately after completion of the hemodialysis session.
Immediately after completion of the hemodialysis session.

二次結果の測定

結果測定
メジャーの説明
時間枠
Change in Pain Score
時間枠:Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in pain score measured using the Visual Analog Scale for Pain (VAS-P), a 0-10 scale where 0 indicates no pain and 10 indicates the worst possible pain. Higher scores indicate greater pain. Pain was assessed before and immediately after completion of the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Participant Satisfaction Score
時間枠:Immediately after completion of the hemodialysis session.
Participant satisfaction with the virtual reality intervention measured using the Visual Analog Scale for Satisfaction (VAS-S), a 0-10 scale where 0 indicates not satisfied at all and 10 indicates completely satisfied. Higher scores indicate greater participant satisfaction. Assessment was performed immediately after completion of the hemodialysis session.
Immediately after completion of the hemodialysis session.

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • スタディディレクター:Hilal Tüzer, Assoc. Prof.、Ankara Yildirim Beyazıt University

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2023年5月3日

一次修了 (実際)

2024年5月27日

研究の完了 (実際)

2024年5月27日

試験登録日

最初に提出

2026年6月28日

QC基準を満たした最初の提出物

2026年7月9日

最初の投稿 (実際)

2026年7月15日

学習記録の更新

投稿された最後の更新 (実際)

2026年7月15日

QC基準を満たした最後の更新が送信されました

2026年7月9日

最終確認日

2026年6月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

未定

IPD プランの説明

The decision regarding sharing of individual participant data has not yet been finalized. Any future data sharing will be considered in accordance with institutional policies, ethical requirements, and applicable regulations.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する